- Active not recruiting
Anticoagulation in Patients With Venous Thromboembolism and Cancer
This study looks back at patient records to understand how different blood-thinning medicines work for people with cancer who have also had blood clots. It compares medicines like Apixaban, Rivaroxaban, and Dabigatran to see which are most effective and safe.
For: Neoplasms · EmbolismUnited Kingdom - Active not recruitingPHASE4
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
This study looks at whether a blood-thinning medicine called edoxaban can reduce the risk of stroke in people with an irregular heartbeat (atrial fibrillation) who have previously had bleeding in the brain. It compares edoxaban to not taking blood thinners.
For: Intracranial Hemorrhages · Atrial FibrillationUnited States · Argentina · Austria - RecruitingPHASE4
Dabigatran vs. Oral Anti-Xa Inhibitors in S. Aureus Bacteremia
This study compares different blood thinners (Dabigatran vs. Apixaban, Edoxaban, or Rivaroxaban) in people with a serious স্টাফ infection (S. aureus bacteremia). We want to see if switching to dabigatran, which might fight the infection, improves outcomes for patients already taking blood thinners.
For: Staphylococcus Aureus Endocarditis · Staphylococcus Aureus Septicemia · Staphylococcus Aureus BacteremiaCanada